MedTrace Logo

Intramural Needle Ablation for Ventricular Tachycardia

NCT02799693 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 4

Last updated 2022-03-15

No results posted yet for this study

Summary

This is a single-arm non-randomized prospective observational cohort study to assess the outcomes of patients undergoing intramural needle catheter ablation of recurrent ventricular tachycardia that has failed antiarrhythmic drug therapy and standard radiofrequency (RF) catheter ablation. Following ablation, patients will be monitored for 6 months. The duration of the study is up to 4 years.

Conditions

  • Recurrent Ventricular Tachycardia

Sponsors & Collaborators

  • John Sapp

    lead OTHER

Principal Investigators

  • John Sapp, MD FRCPC · Nova Scotia Health Authority

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-07-31
Primary Completion
2018-04-05
Completion
2018-05-30

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02799693 on ClinicalTrials.gov